Contrast echocardiography guidance for alcohol septal ablation of hypertrophic obstructive cardiomyopathy.
نویسندگان
چکیده
in patients with coronary artery disease. J Am Coll Cardiol 2009;53:323–330. 37. Mahmud FH, Earing MG, Lee RA, Lteif AN, Driscoll DJ, Lerman A. Altered endothelial function in asymptomatic male adolescents with type 1 diabetes. Congenit Heart Dis 2006;1:98–103. 38. Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 2008;51:997–1002. 39. Selamet Tierney ES, Newburger JW, Gauvreau K, Geva J, Coogan E, Colan SD, Ferranti SD. Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr 2009;154:901–905. 40. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA 2007;297:611–619. 41. Nasir K, Michos ED, Blumenthal RS, Raggi P. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol 2005;46:1931–1936. 42. Grewal J, Anand S, Islam S, Lonn E, SHARE, SHARE-AP Investigators. Prevalence and predictors of subclinical atherosclerosis among asymptomatic ‘low risk’ individuals in a multiethnic population. Atherosclerosis 2008;197: 435–442. 43. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006;184: 201–206. 44. Lerman A, Sopko G. Women and cardiovascular heart disease: clinical implications from the Women’s Ischemia Syndrome Evaluation (WISE) study. Are we smarter? J Am Coll Cardiol 2006;47(Suppl. 3):S59–S62. 45. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009;169:843–850. 46. The national inpatient sample for 2006 (ICD 9, code 411.89). http://www.hcup-us .ahrq.gov/ (7 May 2009).
منابع مشابه
Alcohol Ablation in Hypertrophic Cardiomyopathy: Localization and Quantification of Target Septal Artery-dependent Myocardium With 3-Dimensional Echocardiography.
Alcohol septal ablation (ASA) aims to reduce the subaortic gradient in patients with symptomatic hypertrophic obstructive cardiomyopathy using alcohol to induce septal necrosis. Our aim was to describe the usefulness of 3-dimensional (3D) transthoracic echocardiography (TTE) with contrast in the localization and quantification of the extent of septal artery-dependent territory. From 2012 onward...
متن کاملTwenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Hypertrophic obstructive cardiomyopathy is the most common genetic cardiac disease and is generally characterised by asymmetric septal hypertrophy and intraventricular obstruction. Patients with severe obstruction and significant symptoms that persist despite optimal medical treatment are candidates for an invasive septal reduction therapy. Twenty years after its introduction, percutaneous tran...
متن کاملHypertrophic obstructive cardiomyopathy: alcohol septal ablation
Alcohol septal ablation (ASA) was introduced in 1994 as an alternative to septal myectomy for patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy. This procedure alleviates symptoms by producing a targeted, limited infarction of the upper interventricular septum, resulting in an increase in left ventricular outflow tract (LVOT) diameter, a decrease i...
متن کاملCurrent status of nonsurgical septal reduction therapy in hypertrophic obstructive cardiomyopathy
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy patients has been available since 1994. Medium-term case series following alcohol septal ablation (ASA) are now available. Procedural risk is low and a significant improvement in symptom burden and left ventricular outflow tract gradient is observed in most cases. Success to medium-term is comparable to surgical se...
متن کاملDetection of myocardial infarction by delayed contrast-enhanced multislice computed tomography.
1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211–214. 2. Lakkis N, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III. Echocardiography-guided ethanol septal ablation for hypertrophic obstructive cardiomyopathy. Circulation 1998;98: 1750–1755. 3. Knight C. Alcohol septal ablation for obstructive hypertroph...
متن کاملAlcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Since its original description in 1994, alcohol septal ablation (ASA) has emerged as a minimally invasive modality for treatment of hypertrophic obstructive cardiomyopathy compared to surgical myomectomy. This catheter-based intervention relies on the injection of absolute alcohol into the septal perforator to induce a controlled infarction of the hypertrophied septum and consequently abolish t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European heart journal
دوره 31 9 شماره
صفحات -
تاریخ انتشار 2010